Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Supplementation with active hexose correlated compound increases survival following infectious challenge in mice.

Ritz BW.

Nutr Rev. 2008 Sep;66(9):526-31. doi: 10.1111/j.1753-4887.2008.00085.x. Review.

PMID:
18752476
2.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
3.
4.

Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.

Van Reeth K, Braeckmans D, Cox E, Van Borm S, van den Berg T, Goddeeris B, De Vleeschauwer A.

Vaccine. 2009 Oct 23;27(45):6330-9. doi: 10.1016/j.vaccine.2009.03.021.

PMID:
19840669
5.

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.

Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G.

Am J Surg. 2008 Apr;195(4):537-45. doi: 10.1016/j.amjsurg.2007.05.045.

PMID:
18304499
6.

Infection and immunoglobulin concentrations in Chediak-Higashi mice.

Elin RJ, Edelin JB, Wolff SM.

Infect Immun. 1974 Jul;10(1):88-91.

7.

[The role of cellular and humoral factors of body resistance in the development of experimental influenza-staphylococcal infections in mice].

Lavrov VF, Orlova NG, Ratgauz GL, Akatov AK, Ageeva ON.

Zh Mikrobiol Epidemiol Immunobiol. 1989 Apr;(4):73-6. Russian.

PMID:
2735172
8.

Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Vaccine. 2009 Aug 6;27(36):4983-9. doi: 10.1016/j.vaccine.2009.05.079. Epub 2009 Jun 16.

PMID:
19538996
9.

Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection.

Aviles H, O'Donnell P, Sun B, Sonnenfeld G.

Surg Infect (Larchmt). 2006 Dec;7(6):527-35.

PMID:
17233570
10.

Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

D'Aoust MA, Lavoie PO, Couture MM, Trépanier S, Guay JM, Dargis M, Mongrand S, Landry N, Ward BJ, Vézina LP.

Plant Biotechnol J. 2008 Dec;6(9):930-40. doi: 10.1111/j.1467-7652.2008.00384.x.

11.

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.

Vaccine. 2009 Nov 5;27(47):6512-21. doi: 10.1016/j.vaccine.2009.08.053. Epub 2009 Sep 1.

PMID:
19729082
12.

[Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal opportunistic infections in mice].

Ishibashi H, Ikeda T, Tansho S, Ono Y, Yamazaki M, Sato A, Yamaoka K, Yamaguchi H, Abe S.

Yakugaku Zasshi. 2000 Aug;120(8):715-9. Japanese.

PMID:
10946621
13.

Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.

Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O.

Vaccine. 2008 Dec 9;26(52):6965-74. doi: 10.1016/j.vaccine.2008.09.051. Epub 2008 Oct 9.

PMID:
18848593
14.

Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir.

Koudstaal W, Koldijk MH, Brakenhoff JP, Cornelissen LA, Weverling GJ, Friesen RH, Goudsmit J.

J Infect Dis. 2009 Dec 15;200(12):1870-3. doi: 10.1086/648378.

PMID:
19911992
15.

Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus.

Cheng VC, Lau YK, Lee KL, Yiu KH, Chan KH, Ho PL, Yuen KY.

J Infect. 2009 Nov;59(5):366-70. doi: 10.1016/j.jinf.2009.08.021. Epub 2009 Sep 9.

PMID:
19747506
16.

Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2003 Aug;95(2):491-6. Epub 2003 Apr 11.

17.

[Emergency prophylactic effects of the avian influenza virus immunized serum on the infected mice].

Wang CY, Wang HL, Feng N, Yang ST, Gao YW, Wang TC, Zou XH, Xia XZ.

Zhonghua Yu Fang Yi Xue Za Zhi. 2008 Nov;42(11):814-7. Chinese.

PMID:
19176141
18.

A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.

Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z.

J Infect Dis. 2009 Dec 15;200(12):1874-83. doi: 10.1086/648405.

PMID:
19909080
19.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270
20.

[Enhanced nonspecific anti-infective resistance of animals with the use of a polysaccharide complex of plant origin].

Goncharov AI.

Zh Mikrobiol Epidemiol Immunobiol. 1982 May;(5):89-94. Russian.

PMID:
7102185

Supplemental Content

Support Center